Achievement of Guidance and Revenue Growth
Siemens Healthineers closed fiscal year '25 successfully, achieving the upper end of their guidance range with broad-based growth in all regions except China. An overall book-to-bill ratio of 1.14 was reported for the fiscal year.
Impressive Segment Performance
Revenue from Imaging, Varian, and Advanced Therapies increased by almost 8%, with Imaging showing continued margin expansion. Varian has grown every year by at least high single-digit percentages since the combination, and Advanced Therapies maintained solid growth by keeping margins stable.
Free Cash Flow Improvement
Siemens Healthineers improved its free cash flow throughout the year, lowering leverage to 2.8x EBITDA, and announced a proposed dividend increase to EUR 1.
Strong Performance of Photon Counting CT and PETNET
Photon Counting CT and PETNET were highlighted as strong growth drivers in Imaging, contributing to a 6.5% revenue increase versus tough prior year comparisons.